Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 852227-90-8 | MDL No. : | MFCD08060504 |
Formula : | C16H24BNO2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | DWJNNJSONWFVBT-UHFFFAOYSA-N |
M.W : | 273.18 | Pubchem ID : | 18525715 |
Synonyms : |
|
Num. heavy atoms : | 20 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.62 |
Num. rotatable bonds : | 2 |
Num. H-bond acceptors : | 2.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 87.56 |
TPSA : | 21.7 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | Yes |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | Yes |
CYP3A4 inhibitor : | Yes |
Log Kp (skin permeation) : | -5.47 cm/s |
Log Po/w (iLOGP) : | 0.0 |
Log Po/w (XLOGP3) : | 3.52 |
Log Po/w (WLOGP) : | 2.21 |
Log Po/w (MLOGP) : | 2.17 |
Log Po/w (SILICOS-IT) : | 2.21 |
Consensus Log Po/w : | 2.02 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -3.84 |
Solubility : | 0.0394 mg/ml ; 0.000144 mol/l |
Class : | Soluble |
Log S (Ali) : | -3.66 |
Solubility : | 0.0598 mg/ml ; 0.000219 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -4.44 |
Solubility : | 0.0099 mg/ml ; 0.0000362 mol/l |
Class : | Moderately soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 2.87 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
66% | With (1,1'-bis(diphenylphosphino)ferrocene)palladium(II) dichloride; potassium acetate In 1,4-dioxaneReflux; Inert atmosphere | An argon-purged 1,4-dioxane (30 mL) wasadded to a flask containing bromophenylpyrrolidine 5b (722mg, 3.19mmol), (BPin)2 (= bis(pinacolato)diboron (1.21 g,4.78mmol), AcOK (939 mg, 9.56mmol), and PdCl2(dppf )(dppf = 1,1-bis(diphenylphosphino)ferrocene, 79 mg, 0.097mmol) and the mixture was refluxed under argon for 14 h.The reaction mixture was extracted with hexane, which wasdried over Na2SO4 and evaporated. The obtained residuewas chromatographed (SiO2, hexane/AcOEt = 17:3) to affordblack-red needles (575 mg, 2.10mmol, 66percent). TLC (SiO2,CHCl3): Rf = 0.60. 1H NMR (CDCl3): δ (ppm) = 1.32 (12H,s), 1.92.1(4H, m), 3.23.4(4H, m), 6.53 (2H, dd, J = 6.5,1.8 Hz), 7.67 (2H, dd, J = 6.5, 1.8 Hz). APCI-MS (CHCl3):m/z calcd for C16H25BNO2 ([MH]+), 274.1973; found,274.2256 |
[ 267221-88-5 ]
N,N-Diphenyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline
Similarity: 0.94
[ 656257-45-3 ]
4-(4-Ethylpiperazin-1-yl)phenylboronic acid pinacol ester
Similarity: 0.93
[ 171364-78-6 ]
N,N-Dimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline
Similarity: 0.92
[ 1256360-63-0 ]
N-Isopropyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline
Similarity: 0.89
[ 568577-88-8 ]
4-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)morpholine
Similarity: 0.87
[ 267221-88-5 ]
N,N-Diphenyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline
Similarity: 0.94
[ 656257-45-3 ]
4-(4-Ethylpiperazin-1-yl)phenylboronic acid pinacol ester
Similarity: 0.93
[ 171364-78-6 ]
N,N-Dimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline
Similarity: 0.92
[ 1256360-63-0 ]
N-Isopropyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline
Similarity: 0.89
[ 568577-88-8 ]
4-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)morpholine
Similarity: 0.87
[ 656257-45-3 ]
4-(4-Ethylpiperazin-1-yl)phenylboronic acid pinacol ester
Similarity: 0.93
[ 568577-88-8 ]
4-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)morpholine
Similarity: 0.87
[ 852227-95-3 ]
4-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]morpholine
Similarity: 0.86
[ 884507-39-5 ]
1-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)pyrrolidine
Similarity: 0.81
[ 470478-90-1 ]
tert-Butyl 4-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)piperazine-1-carboxylate
Similarity: 0.73
[ 884507-39-5 ]
1-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)pyrrolidine
Similarity: 0.81
[ 229009-41-0 ]
(4-(Pyrrolidin-1-yl)phenyl)boronic acid
Similarity: 0.72
[ 659731-18-7 ]
3-(Pyrrolidino)phenylboronic acid
Similarity: 0.71
[ 1356111-39-1 ]
1-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)cyclohex-3-en-1-yl)pyrrolidine
Similarity: 0.66
[ 1000802-52-7 ]
1-(2-(Pyrrolidin-1-yl)ethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole
Similarity: 0.58